Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
DUBLIN, Feb. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today announced that the Company has received an Acceptable for Filing letter from the U.S. Food and Drug Administration (FDA) ... Biopharmaceuticals, Generics, Gastroenterology, FDAAllergan, Valeant Pharmaceuticals, IFAXAN, rifaximin, irritable bowel syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Allergy | Food and Drug Administration (FDA) | Gastroenterology | Irritable Bowel Syndrome | Marketing | Pharmaceuticals | Xifaxan